Skip to content
Government-backed FundPuts its own capital into companiesActive · deal in last 18 monthsLAST VERIFIED Oct 2026 · 16 SOURCES

NRW.BANK

100% owned by Land Nordrhein-Westfalen

Also known as NRW.Venture, NRW Bank

Development bank of North Rhine-Westphalia, 100% owned by the Land; invests equity directly (NRW.Venture, up to €15m per start-up) and as LP in VC/PE funds; 62 companies and 72 funds at end-2024.

State development bank of North Rhine-Westphalia (Düsseldorf/Münster); not to be confused with KBG NRW (the NRW Mittelständische Beteiligungsgesellschaft) or with NBank (Lower Saxony).

HEADQUARTERS
Düsseldorf, Germany
FOUNDED
2002
OUTSIDE CAPITAL
No — own capital only
TEAM LISTED
19 people

Focus

STAGES
Pre-SeedSeedSeries ASeries BGrowthBuyout
ASSET MIX
Direct investmentsVenture capitalFunds (as LP)
GEOGRAPHY
Germany

Investment arms & vehicles

  • NRW.BANK's venture capital fund: minority stakes of up to €15m over several rounds in NRW start-ups, alongside private investors
  • Fund launched February 2026 under InvestEU allowing total commitments of up to €30m in NRW scale-ups
  • Seed co-investment programme
  • Ruhr-region seed fund whose managing director and Prokurist come from the NRW.BANK venture team

Overview

NRW.BANK is the development bank of North Rhine-Westphalia, a public-law institution owned 100% by the Land NRW, with seats in Düsseldorf and Münster. Besides promotional loans it provides mezzanine and equity financing across the company life cycle, from pre-seed to growth, succession and restructuring, and invests in VC and PE funds. Through its venture capital fund NRW.Venture it takes minority stakes of up to €15m over several rounds in NRW start-ups alongside private investors; in February 2026 it launched NRW.Venture EU Tech&Scale, which allows up to €30m per scale-up as an InvestEU implementing partner. At 31 December 2024 its equity division held 62 companies and 72 funds.

Investment thesis

Minority equity stakes, over three to seven years, in innovative, often technology-oriented NRW start-ups that have closed a seed, business-angel or first VC round, co-investing with private investors; focus areas ICT/AI/enterprise software/IT security and life sciences/cleantech; fund investments to develop the VC and PE market in NRW.

PORTFOLIO (63)

  • Biotech & Life Sciences
  • Biotech & Life Sciences
  • Deep Tech
  • clockin
    Software & SaaS · since 2025
  • HealthTech
  • Cylib
    Climate & Energy
  • Biotech & Life Sciences
  • eeden
    Climate & Energy · since 2025
  • Deep Tech
  • Biotech & Life Sciences · since 2026
  • Lidrotec
    Industrial & Manufacturing · since 2025
  • Biotech & Life Sciences
  • Artificial Intelligence
  • HealthTech
  • Software & SaaS
  • Software & SaaS
  • Vytal Global
    Climate & Energy · since 2025
  • Software & SaaS · Exited
  • JUPUS GmbH
    Artificial Intelligence · since 2026
  • eleQtron GmbH
    Deep Tech · since 2026
  • Co-reactive
    Climate & Energy · since 2026
  • ag-tech.systems GmbH
    Food & Agriculture · since 2026
  • Saperatec
    Climate & Energy
  • Innolume
    Deep Tech
  • Enerthing
    Climate & Energy
  • ubirch
    Software & SaaS
  • Direvo Industrial Biotechnology
    Biotech & Life Sciences
  • Novihum Technologies
    Climate & Energy
  • GreenPocket
    Software & SaaS
  • Resolve BioSciences
    Biotech & Life Sciences
  • Deutsche Arzt AG
    HealthTech
  • Personal MedSystems
    HealthTech
  • Cellink
    Biotech & Life Sciences
  • octonomy
    Artificial Intelligence
  • Enlyze
    Software & SaaS
  • Hemovent
    HealthTech
  • Femtos
  • Occlutech
    HealthTech
  • Bomedus
    HealthTech
  • CEVEC Pharmaceuticals
    Biotech & Life Sciences
  • AyoxxA Biosystems
    Biotech & Life Sciences
  • Algiax Pharmaceuticals
    Biotech & Life Sciences
  • aifora
    Software & SaaS
  • Compeon
    Software & SaaS
  • Rigontec
    Biotech & Life Sciences · Exited
  • Scienion
    Biotech & Life Sciences · Exited
  • evoxx technologies
    Biotech & Life Sciences · Exited
  • O-flexx Technologies
    Climate & Energy · Exited
  • CellAct Pharma
    Biotech & Life Sciences · Exited
  • Neo New Oncology
    Biotech & Life Sciences · Exited
  • Protagen
    Biotech & Life Sciences · Exited
  • amber
    Artificial Intelligence · since 2026
  • Talpasolutions GmbH
    Software & SaaS
  • VTI Ventiltechnik GmbH
    Industrial & Manufacturing
  • Schoellershammer GmbH
    Industrial & Manufacturing
  • Phenox GmbH
    HealthTech · Exited
  • Emergence Therapeutics AG
    Biotech & Life Sciences · Exited
  • Frontastic GmbH
    Software & SaaS · Exited
  • Holobuilder Inc.
    Software & SaaS · Exited
  • Butlers GmbH & Co. KG
    Consumer & E-commerce · Exited
  • d.velop AG
    Software & SaaS · Exited

People

  • Gabriela Pantring
    Chair of the Managing Board (Vorsitzende des Vorstands) · source
  • Dr. Peter Stemper
    Deputy Chair of the Managing Board · source
  • Claudia Hillenherms
    Member of the Managing Board · source
  • Johanna Antonie Tjaden-Schulte
    Member of the Managing Board · source
  • Dr. Claas Heise
    Head of Venture Capital and fund investments (NRW.Venture) · source
  • Dr. Thomas Raueiser
    Head of Life Sciences & Cleantech team; Prokurist, Gründerfonds Ruhr · source
  • Thorsten Reuter
    Head of Digital Economy & Technology team; Managing Director, Gründerfonds Ruhr · source
  • Thorsten Heldt
    Senior Investment Manager, Digital Economy & Technology (deputy team head) · source
  • Dr. Marek Kozlowski
    Senior Investment Director, Life Science & Cleantech · source
  • Massi Ali Ahmadi
    Investment Manager, Digital Economy & Technology · source
  • Dr. Maria Bräutigam
    Investment Manager, Life Science & Cleantech · source
  • Maximilian Erb
    Investment team, Life Sciences & Cleantech · source
  • Tim Gudelj
    Investment team, Digitalisation & Technology · source
  • Philipp Leidig
    Investment team, Life Sciences & Cleantech · source
  • Dr. Vera Mehler-de Graaff
    Investment team, Life Science & Cleantech · source
  • Patrick Nesseler
    Investment Manager, Digital Economy & Technology · source
  • Dr. Antonia Nörthemann
    Investment Manager, Digital Economy & Technology · source
  • Florian Stinauer
    Investment team, Life Sciences & Cleantech · source
  • Jonas Vonnahme
    Investment team, Life Science & Cleantech · source

Links

Frequently asked questions

NRW.BANK is a government-backed fund based in Düsseldorf, Germany, founded in 2002.

Yes. NRW.BANK invests its own capital in private companies. It also commits capital to third-party funds as an LP.

NRW.BANK invests at Pre-Seed, Seed, Series A, Series B, Growth and Buyout stages in Software & SaaS, Artificial Intelligence, Biotech & Life Sciences, HealthTech, Climate & Energy, Deep Tech and Industrial & Manufacturing.

NRW.BANK's stated ticket size is €50K–€15M.

Key people at NRW.BANK include Gabriela Pantring (Chair of the Managing Board (Vorsitzende des Vorstands)), Dr. Peter Stemper (Deputy Chair of the Managing Board), Claudia Hillenherms (Member of the Managing Board) and Johanna Antonie Tjaden-Schulte (Member of the Managing Board).

NRW.BANK's investments include 4TEEN4 Pharmaceuticals, Abalos Therapeutics, Black Semiconductor, clockin, Cryotherapeutics, Cylib, Dimate and Disco Pharmaceuticals, among others.

The most recent publicly reported investment by NRW.BANK is ag-tech.systems GmbH (Seed), announced in Aug 2026.

NRW.BANK states that it accepts submissions through its official contact page.

No. NRW.BANK invests its own capital and does not raise money from outside investors.